Cyrus Biotechnology

Cyrus Biotechnology

Signal active

Organization

Contact Information

Overview

Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools.

It was founded in 2014 and headquartered in Seattle, Washington.

About

Industries

Software, Biotechnology, Nutrition

Founded

2014

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Cyrus Biotechnology headquartered in United States, North America, operates in the Software, Biotechnology, Nutrition sector. The company focuses on Software and has secured $5.6B in funding across 120 round(s). With a team of 11-50 employees, Cyrus Biotechnology is actively contributing to advancements in Software. Their latest funding round, Seed Round - Cyrus Biotechnology, raised $850.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Mark B. Benjamin

Mark B. Benjamin

President and EVP Business Development

imagePlace Lucas Nivon

Lucas Nivon

Co-Founder & CEO

imagePlace Yifan Song

Yifan Song

Chief Science Officer & Co-Founder

imagePlace Eric Tarcha

Eric Tarcha

Vice President, Drug Discovery

Funding Rounds

Funding rounds

10

Investors

2

Lead Investors

0

Total Funding Amount

$46.8M

Details

7

Cyrus Biotechnology has raised a total of $46.8M in funding over 7 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Early Stage Venture18.0M
2024Early Stage Venture
2017Early Stage Venture8.0M
2015Seed850.0K

Investors

Cyrus Biotechnology is funded by 25 investors.

Investor NameLead InvestorFunding RoundPartners
W Fund-FUNDING ROUND - W Fund8.0M
WINGS-FUNDING ROUND - WINGS850.0K
Cyrus Biotechnology-FUNDING ROUND - Cyrus Biotechnology850.0K
W Fund-FUNDING ROUND - W Fund850.0K

Recent Activity

There is no recent news or activity for this profile.